A summary of Helix BioMedix Drug Discovery and Development
Programs focusing on the Company’s initial candidates in the areas
of anti-infective, anti-fungal and MRSA fighting peptides based on
the innate immune system.
A summary of Helix BioMedix Drug Discovery and Development
Programs focusing on the Company’s initial candidates in the areas
of anti-infective, anti-fungal and MRSA fighting peptides based on
the innate immune system…click to learn more.
We are developing a novel, broad-spectrum, topical anti-infective
for the treatment of skin and wound infections and the prevention of
Staphylococcus aureus. Our pre-clinical data have shown that our lead
molecules are capable of treating Trichophyton infections and hold
great promise for multiple dermatological indications…click to
learn more.
Our pre-clinical data have shown that our lead molecules
are capable of treating Trichophyton infections and hold great promise
for multiple dermatological indications…click to learn more.
Acne, rosacea, fungal conditions and MRSA are common
problems facing today’s dermatologists…click to learn more.
Product Pipeline
The Helix BioMedix Drug Discovery and Development Programs focus on
the Company’s lead candidates in the areas of anti-infective, anti-fungal
and anti-inflammatory peptides based on the innate immune system. With
an initial focus on peptides for the treatment of acne and MRSA (Methicillin-resistant
Staphylococcus aureus), Helix BioMedix has targeted markets with high
demand and unmet needs.
